2011 to 2017 Saw Increase in Spending on DMTs for MS

WEDNESDAY, Jan. 15, 2020 -- From 2011 to 2017, there was an increase in gross annual expenditures on multiple sclerosis (MS) disease-modifying therapies (DMTs), with increased spending mainly driven by increases in per-prescription costs, according...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news

Related Links:

Publication date: Available online 26 May 2020Source: NeuroImage: ClinicalAuthor(s): Kl. West, Dk. Sivakolundu, Gb. Maruthy, Md. Zuppichini, P. Liu, Bp. Thomas, Js. Spence, H. Lu, Dt. Okuda, B. Rypma
Source: NeuroImage: Clinical - Category: Radiology Source Type: research
Publication date: Available online 26 May 2020Source: NeuroImage: ClinicalAuthor(s): Chanon Ngamsombat, Qiyuan Tian, Qiuyun Fan, Andrew Russo, Natalya Machado, Maya Polackal, Ilena C. George, Thomas Witzel, Eric C. Klawiter, Susie Y. Huang
Source: NeuroImage: Clinical - Category: Radiology Source Type: research
Publication date: Available online 30 May 2020Source: Multiple Sclerosis and Related DisordersAuthor(s): R.D. Russell, L.J. Black, N.M. Pham, A. Begley
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research
Publication date: August 2020Source: Multiple Sclerosis and Related Disorders, Volume 43Author(s): Amgad Droby, Lazar Fleysher, Maria Petracca, Kornelius Podranski, Junqian Xu, Michelle Fabian, Malgorzata Marjańska, Matilde Inglese
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research
Publication date: Available online 29 May 2020Source: Multiple Sclerosis and Related DisordersAuthor(s): Helena Beatriz Ferreira, Bruna Neves, Inês M. Guerra, Ana Moreira, Tânia Melo, Artur Paiva, M. Rosário Domingues
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research
CONCLUSION: On the basis of a broadly based research and participatory development process, a set of indicators has been developed that enables comprehensive evaluation of the regional quality of care of cross-indication, integrated care models focusing on common diseases. In order to be able to increasingly evaluate aspects of care coordination and patient orientation, health promotion as well as nursing, palliative and emergency care in the future, it would be helpful if routine data were collected or made accessible in these areas as well. PMID: 32467041 [PubMed - as supplied by publisher]
Source: Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen - Category: Health Management Tags: Z Evid Fortbild Qual Gesundhwes Source Type: research
TRIUMPHANT, a new placebo-controlled trial, has not shown any benefit over placebo of three different drugs commonly used to treat fatigue in patients with multiple sclerosis.Medscape Medical News
Source: Medscape Psychiatry Headlines - Category: Psychiatry Tags: Neurology & Neurosurgery News Source Type: news
Conditions:   Multiple Sclerosis;   Menstrual Pain;   Anxiety;   Fatigue;   Neurologic Symptoms Interventions:   Other: pain;   Other: fatigue;   Other: anxiety;   Other: position sense;   Other: balance;   Other: dual task performance Sponsor:   Ankara Yildirim Beyazıt University Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Multiple Sclerosis;   Traumatic Brain Injury Interventions:   Behavioral: Emotional Processing Training;   Behavioral: Placebo Control Sponsor:   Kessler Foundation Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Multiple Sclerosis;   Menstrual Pain;   Anxiety;   Fatigue;   Neurologic Symptoms Interventions:   Other: pain;   Other: fatigue;   Other: anxiety;   Other: position sense;   Other: balance;   Other: dual task performance Sponsor:   Ankara Yildirim Beyazıt University Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Expenditures | Multiple Sclerosis | Pharmaceuticals